Seoul National University Bundang Hospital (SNUBH)
Glaucoma treatment cost in the Republic of Korea typically ranges from $100 for a detailed ophthalmological investigation to $200 for specialist consultations. Total expenses generally depend on the disease stage and whether laser therapy or surgical intervention is required. Patients can expect approximately 20-40% savings compared to the US, with top-tier care concentrated in Seoul, Incheon, and Busan.
Typical Glaucoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: Early-stage patients benefit most from digital monitoring at specialized centers like Seoul National University Bundang Hospital (SNUBH), which utilizes the BESTcare digital system. For complex cases, JCI-accredited Severance Hospital offers advanced ophthalmology departments with high safety standards. Patients seeking expert surgical care can find board-certified specialists at Gangnam Grand Eye Clinic, where doctors have performed over 30,000 procedures.
| Republic of Korea | Turkey | Austria | |
| Trabeculotomy | - | from $1,500 | from $2,500 |
| Laser trabeculoplasty | - | from $500 | from $1,500 |
No hidden fees – just official clinic prices. Pay at the clinic for Glaucoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Glaucoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Glaucoma treatment journey.
Successfully treated over 500,000 patients – Dr. Chong Gi Von is a leading specialist in advanced eye surgeries at BGN Eye Hospital.
Dr. Jinchul Kim is the Director and Ophthalmologist at Samsung Miracle Eye Clinic in Gangnam, Seoul. He specializes in refractive surgery, including SMILE and laser procedures, and in cataract and IOL surgery with custom lens planning. He earned his M.D. from Seoul National University College of Medicine. He completed specialist training in ophthalmology at Samsung Seoul Hospital and now serves as a Visiting Professor there. He also received advanced clinical training at the Mayo Clinic in the United States.
His achievements include the “Miracle Formula,” the world’s first IOL power calculation program tailored to Asian biometric profiles (patent pending). He holds ZEISS SMILE Excellent Surgeon certification. He has been invited to lecture at the IOL Power Club 2025 (first Korean invitee), ASCRS 2025, and ESCRS 2023. His professional memberships include KOS, AAO, APAO, ESCRS, ASCRS, APACRS, KEEDS, and KCLS.
Dr. Yoon-Jung Jo is a board-certified ophthalmologist and Director at Samsung Miracle Eye Clinic (Gangnam, Seoul). She earned her MD and completed an ophthalmology residency at Hallym University Medical Center. She later served as a visiting professor and clinical faculty member. She also served as Director of Cheonan Kim Eye Clinic.
She is a refractive surgery specialist. Her focus includes SMILE, LASIK, and 1:1 customized astigmatism and vision correction. Dr. Jo is a certified ZEISS SMILE Excellent Surgeon. She is an active member of KOS, AAO, APAO, KSCRS, ESCRS, ASCRS, ARVO, KEEDS, and KCLS.
Dr. Seong-Won Cho is Director of Ophthalmology and a refractive surgery specialist at Samsung Miracle Eye Clinic in Gangnam, Seoul. He is board-certified. He completed his internship and ophthalmology residency at Korea University Anam Hospital. He earned a bachelor’s degree from Boston University. He focuses on advanced vision correction, including SMILE and LASIK. He previously served as Director at Blue World Eye Clinic. He was also an outpatient ophthalmology consultant at Inha University Hospital.
Accreditations: ZEISS SMILE Excellent Surgeon (Certified). Memberships: Korean Medical Association; Korean Ophthalmological Association; Korean Ophthalmological Society; American Academy of Ophthalmology; Asia Pacific Association of Ophthalmologists; Korean External Eye Study Group; Korean Contact Lens Society; Korean Society of Cataract & Refractive Surgery; European Society of Cataract & Refractive Surgeons; American Society of Cataract & Refractive Surgery; ARVO.
South Korean ophthalmologists adapt glaucoma strategies to address specific East Asian genetic traits. Clinicians focus on Normal-Tension Glaucoma, which affects 77% of Korean patients. High rates of myopia and narrow-angle eye structures also require specialized diagnostic software and preventive laser treatments to manage pressure effectively.
Bookimed Expert Insight: Korean specialists have developed proprietary tools like the Miracle Formula at Samsung Miracle Eye Clinic. This world-first IOL power calculation program specifically accounts for Asian biometric profiles. South Korean centers like Asan Medical Center and Severance Hospital manage massive volumes, serving over 10,000 outpatients daily. This experience allows them to refine treatments for high-myopia cases that are often misdiagnosed elsewhere.
Patient Consensus: Patients note that narrow angles are often discovered without symptoms during routine screenings. Many emphasize the importance of immediate preventive laser care once identified to avoid sudden vision loss.
South Korean eye clinics use deep-learning AI screening and micron-level Swept-Source OCT to detect glaucoma and retinal diseases. These facilities integrate digital imaging into unified surgery planning networks. Leading JCI-accredited centers in Seoul employ Pentacam tomography for 3D corneal mapping to ensure high surgical precision.
Bookimed Expert Insight: A major advantage in South Korea is the use of localized diagnostic algorithms. Dr. Jinchul Kim at Samsung Miracle Eye Clinic developed the Miracle Formula. This program is the first IOL power calculation specifically designed for Asian biometric profiles. Choosing a clinic with such specialized tools often leads to more accurate vision correction results.
Minimally Invasive Glaucoma Surgery (MIGS) is widely available in South Korea at specialized ophthalmology centers. JCI-accredited hospitals in Seoul and Incheon utilize microstents and advanced drainage implants. These procedures typically treat mild-to-moderate glaucoma by lowering intraocular pressure with reduced recovery times.
Bookimed Expert Insight: South Korea is uniquely positioned for glaucoma care because of high-volume centers like Severance Hospital. It serves 1.6 million outpatients annually. This massive scale allows surgeons to gain extensive experience with niche MIGS devices faster than in most countries. When choosing a clinic, prioritize those with specialized Ophthalmology and Otolaryngology departments rather than general surgery centers. These dedicated units often house the latest diagnostic equipment like Optical Coherence Tomography (OCT) required for precise MIGS planning.
Patient Consensus: Patients highlight that MIGS is best for those with mild cases looking to reduce daily eye drops. They note that finding a dedicated glaucoma subspecialist in major Seoul hubs is essential for realistic pressure-lowering results.
Selective laser trabeculoplasty (SLT) is a primary alternative to daily glaucoma medication in South Korea. It effectively lowers intraocular pressure by improving fluid drainage. While not a universal replacement, it significantly reduces dependence on eye drops for patients with open-angle glaucoma.
Bookimed Expert Insight: A distinct pattern in South Korean ophthalmology is the focus on biometric customization. Dr. Jinchul Kim at Samsung Miracle Eye Clinic developed a specialized formula for Asian ocular profiles. This level of anatomical precision improves outcomes for laser and lens-based treatments. For patients, this means more accurate pressure control compared to generic protocols.
Patient Consensus: Patients often choose laser therapy to solve the daily struggle of remembering eye drops. Many note that while the laser provides long-term relief, they appreciate having it as a step to delay more invasive surgery.
South Korean ophthalmic centers routinely perform combined cataract and glaucoma surgery in a single session. Surgeons utilize the same incision to remove the cataract and implement glaucoma drainage. This dual approach effectively lowers intraocular pressure while restoring visual clarity during one recovery window.
Bookimed Expert Insight: South Korea is a strategic choice for Asian patients because specialists like Dr. Jinchul Kim at Samsung Miracle Eye Clinic developed the Miracle Formula. This technology optimizes lens power specifically for Asian eye biometric profiles. Choosing a center focused on these regional characteristics can lead to more predictable refractive outcomes after combined surgery.
Patient Consensus: Patients note that combining procedures simplifies travel logistics. Many emphasize clarifying whether the surgery aims to eliminate eye drops or simply manage pressure levels.
South Korean eye clinics are highly specialized in catering to international patients through dedicated global centers. Major facilities in Seoul and Incheon maintain Global Healthcare Accreditation (GHA). They offer English-speaking coordinators and streamlined diagnostic protocols. Most centers provide fully digitalized medical records to ensure seamless follow-up care abroad.
Bookimed Expert Insight: Data shows a clear distinction between boutique refractive clinics and large tertiary hospitals. While private clinics focus on rapid SMILE laser procedures, international patients with complex conditions like glaucoma should choose tertiary centers like Asan Medical Center. These institutions manage over 11,000 outpatients daily and have the infrastructure to handle the long-term medication planning and detailed English reporting required for chronic eye disease management.
Patient Consensus: Patients note that while clinics are extremely efficient, consultations can feel brief and process-driven. It is important to request physical copies of all imaging and a written long-term medication plan before departing Korea.